Canada’s University of Toronto engineering professor Xilin Liu has joined forces with University of Pennsylvania professor Andrew Richardson for the development of new electronic devices for sleep disorders.

Liu and Richardson will work together to develop next-generation devices for studying sleep modulation and creating new interventions to treat several sleep disorders. 

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Liu will focus on the development of integrated circuits and systems to advance digital communication, machine learning and healthcare.

Under the collaboration, Liu will build fully integrated wireless systems-on-chips, which can modulate sleep behaviour autonomously in pre-clinical studies. 

Both researchers also intend to integrate various neural interfacing capabilities into the system to facilitate precise interventions.

The results from this research are expected to support the advancement of neuromodulation technology, which involves the placement of devices inside the brain, spinal cord or peripheral nerves of a patient.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

These devices will also enable the regulation of neural activity and lower symptoms linked to different disorders. 

Recently, the National Institutes of Health (NIH) allocated $2.2m for Liu’s project through the Research Project Grant Programme.

The project is also supported by industry partners, including Open Ephys and Canadian Microelectronics Corporation.

Liu said: “This is a great sign that NIH recognises the value and impact of this research and the calibre of the team.

“We’re excited to receive this funding and over the next four years we hope to get to a stage where the technology can be used in clinical trials.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact